Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 10961 - 10968 of 11439 results
Recent Developments Regarding Issuer Responsibility for Reviewing Initial Offering Prices of Bonds
November 9, 2011| Blog| Viewpoint
HHS OCR Begins HIPAA Audits
November 9, 2011| Blog| Viewpoint
Senators Kerry & McCain to FTC and Commerce: Get Moving on Final Reports
November 8, 2011| Blog| Viewpoint
Delay in Publication of Sunshine Act Regulations Persists Despite Bipartisan Pressure
November 8, 2011| Blog| Viewpoint
Monday Morning Privacy 101
November 7, 2011| Blog| Viewpoint
Guidance for Biotech/Life Sciences Companies on Avoiding Litigation with Contract Partners
November 1, 2011| Blog| Viewpoint
Staffing Company Ordered to Pay Back Wages to H-1B Employees
November 1, 2011| Blog| Viewpoint
Sunrise Period Ends on October 28th for .XXX Domains
October 26, 2011| Blog| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.